Craig B. Granowitz - Aug 2, 2021 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Chief Medical Officer
Signature
/s/ Craig B. Granowitz, M.D., Ph.D.
Stock symbol
LXRX
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
4
Date filed
8/3/2021, 04:39 PM
Next filing
Feb 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +250K $0.00 250K Aug 2, 2021 Common Stock 250K $3.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (8/2/2022) and vests 1/48th per month for each month of service thereafter.